NUsurface Implant Registry

NCT03953846 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2024-07-03

No results posted yet for this study

Summary

The purpose of this active post-market surveillance clinical registry study is to further characterize the therapeutic effect, the long-term safety and effectiveness of the NUsurface® meniscus implant in the real-world post-marketing setting

Conditions

Sponsors & Collaborators

  • Active Implants

    lead INDUSTRY

Principal Investigators

  • Richard W Threharne, PhD · Active Implants LLC

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2023-11-01
Completion
2023-11-01

Countries

  • Belgium
  • Germany
  • Israel
  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03953846 on ClinicalTrials.gov